- Home
- NXTT vs SLRX Comparison
NXTT vs SLRX Comparison
Compare NXTT & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTT
- SLRX
- Stock Information
- Founded
- NXTT 2019
- SLRX N/A
- Country
- NXTT China
- SLRX United States
- Employees
- NXTT 6
- SLRX N/A
- Industry
- NXTT
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- NXTT
- SLRX Health Care
- Exchange
- NXTT NYSE
- SLRX Nasdaq
- Market Cap
- NXTT 933.6M
- SLRX 1.8M
- IPO Year
- NXTT N/A
- SLRX N/A
- Fundamental
- Price
- NXTT $2.02
- SLRX $0.97
- Analyst Decision
- NXTT
- SLRX
- Analyst Count
- NXTT 0
- SLRX 0
- Target Price
- NXTT N/A
- SLRX N/A
- AVG Volume (30 Days)
- NXTT 1.5M
- SLRX 3.5M
- Earning Date
- NXTT 08-20-2025
- SLRX 08-08-2025
- Dividend Yield
- NXTT N/A
- SLRX N/A
- EPS Growth
- NXTT 21.23
- SLRX N/A
- EPS
- NXTT 6.62
- SLRX N/A
- Revenue
- NXTT $1,800,000.00
- SLRX N/A
- Revenue This Year
- NXTT N/A
- SLRX N/A
- Revenue Next Year
- NXTT N/A
- SLRX N/A
- P/E Ratio
- NXTT $0.31
- SLRX N/A
- Revenue Growth
- NXTT N/A
- SLRX N/A
- 52 Week Low
- NXTT $0.22
- SLRX $0.45
- 52 Week High
- NXTT $6.00
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- NXTT 54.62
- SLRX 55.98
- Support Level
- NXTT $1.25
- SLRX $0.61
- Resistance Level
- NXTT $2.62
- SLRX $1.33
- Average True Range (ATR)
- NXTT 0.41
- SLRX 0.14
- MACD
- NXTT 0.07
- SLRX 0.03
- Stochastic Oscillator
- NXTT 40.16
- SLRX 52.84
About NXTT NEXT TECHNOLOGY HOLDING INC
Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.